MedCap AB (publ)

DB:61MA Stock Report

Market Cap: €724.9m

MedCap Future Growth

Future criteria checks 1/6

MedCap is forecast to grow revenue at 13.2% per annum.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Life Sciences earnings growth26.2%
Revenue growth rate13.2%
Future return on equity15.0%
Analyst coverage

Low

Last updated04 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:61MA - Analysts future estimates and past financials data (SEK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,438N/A2684071
12/31/20252,143N/A2163381
12/31/20241,838N/A2433171
9/30/20241,802228251308N/A
6/30/20241,753214244299N/A
3/31/20241,681203219268N/A
12/31/20231,600172189228N/A
9/30/20231,46615077114N/A
6/30/20231,3431496197N/A
3/31/20231,2411234782N/A
12/31/20221,1241184186N/A
9/30/20221,056118100167N/A
6/30/20221,01710778146N/A
3/31/202296710285156N/A
12/31/20219269755116N/A
9/30/20218967677109N/A
6/30/2021869646090N/A
3/31/20218456779104N/A
12/31/20208286391115N/A
9/30/2020802556488N/A
6/30/20207865375101N/A
3/31/2020763473862N/A
12/31/2019757554171N/A
9/30/2019734438087N/A
6/30/20197404170107N/A
3/31/20197273264103N/A
12/31/2018709245691N/A
9/30/2018716141957N/A
6/30/20186898N/A27N/A
3/31/201866010N/A46N/A
12/31/20176177N/A41N/A
10/31/201777911N/A79N/A
7/31/20178023N/A85N/A
4/30/20178530N/A81N/A
1/31/20179015N/A32N/A
10/31/201689710N/A-18N/A
7/31/201687419N/A-44N/A
4/30/201681820N/A-15N/A
1/31/201681718N/A-60N/A
10/31/201581817N/A-28N/A
7/31/20158258N/A14N/A
4/30/20158559N/A2N/A
1/31/20158919N/A50N/A
10/31/201491315N/A26N/A
7/31/201491021N/A-1N/A
4/30/201482723N/A1N/A
1/31/201465118N/A29N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 61MA's forecast earnings growth is above the savings rate (1%).

Earnings vs Market: Insufficient data to determine if 61MA's earnings are forecast to grow faster than the German market

High Growth Earnings: Insufficient data to determine if 61MA's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 61MA's revenue (13.2% per year) is forecast to grow faster than the German market (5.6% per year).

High Growth Revenue: 61MA's revenue (13.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 61MA's Return on Equity is forecast to be low in 3 years time (15%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y